[go: up one dir, main page]

SU1743025A1 - Method of preparing cow anti-coli-proteus lactoglobulin for oral use - Google Patents

Method of preparing cow anti-coli-proteus lactoglobulin for oral use

Info

Publication number
SU1743025A1
SU1743025A1 SU4723050/14A SU4723050A SU1743025A1 SU 1743025 A1 SU1743025 A1 SU 1743025A1 SU 4723050/14 A SU4723050/14 A SU 4723050/14A SU 4723050 A SU4723050 A SU 4723050A SU 1743025 A1 SU1743025 A1 SU 1743025A1
Authority
SU
USSR - Soviet Union
Prior art keywords
lactoglobulin
proteus
coli
oral use
preparation
Prior art date
Application number
SU4723050/14A
Other languages
Russian (ru)
Inventor
С.Г. Благородов
С.В. Соболева
Л.Д. Минеева
Т.А. Федорова
Л.В. Свечникова
А.П. Шепелев
Original Assignee
Ростовский научно-исследовательский институт эпидемиологии, микробиологии и гигиены
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ростовский научно-исследовательский институт эпидемиологии, микробиологии и гигиены filed Critical Ростовский научно-исследовательский институт эпидемиологии, микробиологии и гигиены
Priority to SU4723050/14A priority Critical patent/SU1743025A1/en
Application granted granted Critical
Publication of SU1743025A1 publication Critical patent/SU1743025A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

FIELD: applied immunology. SUBSTANCE: parental raw - colostrum is separated, subjected for treatment with pepsin, prepared lactowhey fractionated with ethanol at cooling, precipitate separated by centrifugation, diluted and clearing filtration is carried out. Then Trilon B and sorbitol were added to solution up to the final concentration 0.05-0.15% and 0.5-1.5%, respectively. Then sterilizing filtration and dosing lactoglobulin pouring into bottles followed by sealing and control of ready product were carried out. Nonspecific activity of preparation (by bactericidal index) is increased to 2.9 as compared with 1.5 by the known method. EFFECT: increased nonspecific activity of preparation.
SU4723050/14A 1989-06-06 1989-06-06 Method of preparing cow anti-coli-proteus lactoglobulin for oral use SU1743025A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4723050/14A SU1743025A1 (en) 1989-06-06 1989-06-06 Method of preparing cow anti-coli-proteus lactoglobulin for oral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4723050/14A SU1743025A1 (en) 1989-06-06 1989-06-06 Method of preparing cow anti-coli-proteus lactoglobulin for oral use

Publications (1)

Publication Number Publication Date
SU1743025A1 true SU1743025A1 (en) 1996-08-10

Family

ID=60532678

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4723050/14A SU1743025A1 (en) 1989-06-06 1989-06-06 Method of preparing cow anti-coli-proteus lactoglobulin for oral use

Country Status (1)

Country Link
SU (1) SU1743025A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2244550C2 (en) * 2003-03-19 2005-01-20 Дальневосточный государственный аграрный университет Method for obtaining biologically active preparation out of colostral whey

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2244550C2 (en) * 2003-03-19 2005-01-20 Дальневосточный государственный аграрный университет Method for obtaining biologically active preparation out of colostral whey

Similar Documents

Publication Publication Date Title
KR100212946B1 (en) Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them
ATE235917T1 (en) USE OF ANTI-TNF ANTIBODIES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF DISEASES INVOLVING ELEVATED INTERLEUKIN-6 SERUM LEVELS
ATE89723T1 (en) RETINOIDS FOR THE TREATMENT OF PHOTODAMAGED SKIN.
DE59209704D1 (en) 2-aminomethyl-chromane as active ingredients in medicinal products for the treatment of diseases of the central nervous system
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE69126039D1 (en) ACTIVE SUBSTANCE FOR HAIR MODIFICATION AND HAIR CARE PRODUCT, WHICH CONTAIN BOTH AN ANTI-KERATINE ANTIBODY, AND PRODUCTION OF THE ANTI-KERATINE ANTIBODY
DK0460169T3 (en) New chroman and thiochromane derivatives
DE60019506D1 (en) Laminaria algae extract, process for their preparation and cosmetic or pharmaceutical compositions containing them
AU667300B2 (en) Immunostimulatory peptide from lactoferrin
DE68929388D1 (en) Anticoagulant compound isolated from urine
DE3575725D1 (en) NEW PYRROLO-BENZIMIDAZOLES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
ATE141613T1 (en) PROCESS FOR PREPARING ASPARTAME FROM A DIKETOPIPERAZINE AND NEW INTERMEDIATE PRODUCTS AND DERIVATIVES THEREFOR
BG47034A3 (en) METHOD FOR THE PREPARATION OF 7-//META-SUBSTITUTED/-PENICILLINS/- -1-CARBA-1-DETHIACEPHALOSPORINS
IL98647A0 (en) Anti-inflammatory factor,processes for the preparation thereof and pharmaceutical compositions containing the same
DE69100293D1 (en) Process for the production of directly stable juices, oils and pomace by squeezing fresh organic products.
SE9704737D0 (en) Immunoglobulin-rich milk, production and use thereof
SU1743025A1 (en) Method of preparing cow anti-coli-proteus lactoglobulin for oral use
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
EP0127712B1 (en) Deodorant containing bacterial antibodies
ATE136896T1 (en) PIPERIDYLMETHYL SUBSTITUTED CHROMEMAN DERIVATIVES AS ACTIVE INGREDIENTS FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
ATE93388T1 (en) MEDICINAL PREPARATION CONTAINING PARACETAMOL.
ATE122100T1 (en) HUMAN MONOCLONAL ANTIBODIES AND MEDICINAL COMPOSITION CONTAINING SAME FOR THE TREATMENT OF PSEUDOMONASIC INFECTIONS.
HUP9901204A2 (en) Novel protein hmw human mp52
ATE119045T1 (en) USE OF RHAMSAN GUM FOR PRODUCING A MEDICINAL PRODUCT FOR TEA TREATMENT.
ATE27157T1 (en) CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.